E

Eric L. Sievers

Seagen (United States)

ORCID: 0000-0002-0794-9441

Publishes on Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, HER2/EGFR in Cancer Research. 155 papers and 14.6k citations.

PubIndex Score89Top 11% · seniorHow it's scored

155Publications

14.6kTotal Citations

First publication: 1985First senior author: 1994

Lymphoma Diagnosis and Treatment Acute Myeloid Leukemia Research HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research CAR-T cell therapy research

Top publicationsby citations

United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia

Steven L. Soignet, Raymond P. Warrell, Stanley R. Frankel et al.|Journal of Clinical Oncology|2001

Cited by 825

Antibody-Drug Conjugates in Cancer Therapy

Eric L. Sievers, Peter D. Senter|Annual Review of Medicine|2012

Cited by 763

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma

Peter D. Senter, Eric L. Sievers|Nature Biotechnology|2012

Cited by 752

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

Eric L. Sievers, Irwin D. Bernstein, F R Appelbaum et al.|Blood|1999

Cited by 456

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

Eric L. Sievers, Irwin D. Bernstein, FO Smith et al.|Blood|1999

Cited by 439